Real World Evidence in CLL
This journal club was a scientific-educational activity discussing the last updated and key points on Management of Acute Lymphoblastic Leukemia.
This journal club was a scientific-educational activity discussing data from BLAST trial, reflecting on the role of achieving and sustaining Minimal Residual Disease negativity status. The Role of Blinatumomab in managing Minimal Residual Disease (MRD) in B-Cell Acute Lymphoblastic Leukemia (B-ALL). One of its key goals was to share clinical experience on the use of […]
Speaker: Dr. Carolina Moreno Affiliations: Associate Progessor of Medicine, Autonomous Univeristy of Barcelona, Senior Consultant, Department of Hematology, Hospital de Saint Paul Santa Creu, Spain. This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2020.
Speaker: Dr. Khalil Al Farsi Affiliations: Senior Consultant in the Hematology/BMT Department, Sultan Qaboos University Hospital, Muscat, Oman This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2020.
Speaker: Dr. Elias Jabbour Affiliations: Professor of Medicine in the Department of Leukemia, University of Texas MD Anderson Cancer Center, United States This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2020.
Speaker: Dr. John M. Pagel Affiliations: Chief of Hematologic Malignancies, Swedish Cancer Institute, United States This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2022.
Speaker: Dr. Pau Montesinos Affiliations: Attending Physician in Department of Hematology, University Hospital La Fe, Valencia, Spain This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2022.